2022: Belastungen im Zusammenhang mit schlechter Arzneimittelqualität in Malawi

This study presents the first findings on the assessment of quality of medicines since the establishment of the national pharmacovigilance center in 2019 in Malawi. It is revealed that the problem of SF medicines is not improving and hence the need for further strengthening of quality assurance systems in Malawi. Full paper here: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0279637

« back